Responses of GLP1-secreting L-cells to cytotoxicity resemble pancreatic β-cells but not α-cells

Journal of Molecular Endocrinology

Volumn 54, Issue 1, 2015, Pages 91-104

  Vasu, Srividya ^a   Charlotte Moffett, R ^a   McClenaghan, Neville H ^a   Flatt, Peter R ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Alpha cells; Beta cells; Cytokine; L cells; Streptozotocin

Indexed keywords

ANTIOXIDANT; CYTOKINE; CYTOTOXIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE TRANSPORTER 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRITE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; GENE; HORMONE RELEASE; IN VITRO STUDY; LD 50; LYMPHOCYTIC INFILTRATION; MIN6 CELL LINE; MOUSE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECRETION (PROCESS); UPREGULATION; ANIMAL; C57BL MOUSE; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; ENDOPLASMIC RETICULUM STRESS; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION; LD50; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-SECRETING CELLS; INSULIN-SECRETING CELLS; LETHAL DOSE 50; MICE, INBRED C57BL; NITRITES; STREPTOZOCIN;

EID: 84923239517     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-14-0214     Document Type: Article

References (45)

1. Andersson AK, Flodstrom M & Sandler S 2001 Cytokine-induced inhibition of insulin release from mouse pancreatic β-cells deficient in inducible nitric oxide synthase. Biochemical and Biophysical Research Communications 281 396–403. (doi:10.1006/bbrc.2001.4361)
2. Bach SP, Renehan AG & Potten CS 2000 Stemcells: the intestinal stemcell as a paradigm. Carcinogenesis 21 469–476. (doi:10.1093/carcin/21.3.469)
3. Baggio LL & Drucker DJ 2007 Biology of incretins: GLP-1 and GIP. Gastroenterology 132 2131–2157. (doi:10.1053/j.gastro.2007.03.054)
4. Basu S, Larsson A, Vessby J, Vessby B & Berne C 2005 Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation. Diabetes Care 28 1371–1375. (doi:10.2337/diacare.28. 6.1371)
5. Bloch K, Shichman E, Vorobeychik M, Bloch D & Vardi P 2007 Catalase expression in pancreatic a cells of diabetic and non-diabetic mice. Histochemistry and Cell Biology 127 227–232. (doi:10.1007/s00418- 006-0248-4)
6. Cani PD, Hoste S, Guiot Y & Delzenne NM 2007 Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. British Journal of Nutrition 98 32–37. (doi:10.1017/ S0007114507691648)
7. Chatzigeorgiou A, Harokopos V, Mylona-Karagianni C, Tsouvalas E, Aidinis V & Kamper EF 2010 The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time. Annals of Medicine 42 426–438. (doi:10.3109/07853890. 2010.495951)
8. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S & Eizirik DL 2005 Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 S 97–107. (doi:10.2337/ diabetes.54.suppl_2.S97)
9. Corbett JA, Sweetland MA, Wang JL, Lancaster JR Jr & McDaniel ML 1993 Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. PNAS 90 1731–1735. (doi:10.1073/ pnas.90.5.1731)
10. Eizirik DL, Kutlu B, Rasschaert J, Darville M & Cardozo AK 2003 Use of microarray analysis to unveil transcription factor and gene networks contributing to β cell dysfunction and apoptosis. Annals of the New York Academy of Sciences 1005 55–74. (doi:10.1196/annals.1288.007)
11. Elsner M, Guldbakke B, Tiedge M, Munday R & Lenzen S 2000 Relative importance of transport and alkylation for pancreatic β-cell toxicity of streptozotocin. Diabetologia 43 1528–1533. (doi:10.1007/ s001250051564)
12. Elsner M, Gurgul-Convey E & Lenzen S 2008 Relation between triketone structure, generation of reactive oxygen species, and selective toxicity of the diabetogenic agent alloxan. Antioxidants & Redox Signaling 10 691–699. (doi:10.1089/ars.2007.1816)
13. Espersen GT, Mathiesen O, Grunnet N, Jensen S & Ditzel J 1993 Cytokine plasma levels and lymphocyte subsets in patients with newly diagnosed insulin-dependent (type 1) diabetes mellitus before and following initial insulin treatment. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 101 703–706. (doi:10.1111/j.1699-0463. 1993.tb00168.x)
14. Flatt PR & Bailey CJ 1981 Abnormal plasma glucose and insulin responses in heterozygous lean (ob/C) mice. Diabetologia 20 573–577. (doi:10.1007/BF00252768)
15. Gao Y, Parker GJ & Hart GW 2000 Streptozotocin-induced β-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells. Archives of Biochemistry and Biophysics 383 296–302. (doi:10.1006/ abbi.2000.2094)
16. Gribble FM 2012 The gut endocrine system as a coordinator of postprandial nutrient homoeostasis. Proceedings of the Nutrition Society 71 456–462. (doi:10.1017/S0029665112000705)
17. Gribble FM, Williams L, Simpson AK & Reimann F 2003 A novel glucosesensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52 1147–1154. (doi:10.2337/ diabetes.52.5.1147)
18. Gurzov EN, Ortis F, Bakiri L, Wagner EF & Eizirik DL 2008 JunB inhibits ER stress and apoptosis in pancreatic β cells. PLoS ONE 3 e3030. (doi:10.1371/journal.pone.0003030)
19. Hamaguchi K & Leiter EH 1990 Comparison of cytokine effects on mouse pancreatic α-cell and β-cell lines. Viability, secretory function, and MHC antigen expression. Diabetes 39 415–425. (doi:10.2337/ diab.39.4.415)
20. Hammed IK, Rashid NF & Abed BA 2012 Serum interleukin-6 level in children with type 1 diabetes mellitus. Journal of the Faculty of Medicine, Baghdad 54 228–230.
21. Hanifi-Moghaddam P, Schloot NC, Kappler S, Seibler J & Kolb H 2003 An association of autoantibody status and serum cytokine levels in type 1 diabetes. Diabetes 52 1137–1142. (doi:10.2337/diabetes.52.5.1137)
22. Ho N, Brookshire BR, Clark JE Lucki I 2014 Indomethacin reverses decreased hippocampal cell proliferation in streptozotocin-induced diabetic mice. Metabolic Brain Disease [in press]. (doi:10.1007/ s11011-014-9611-7)
23. Holst JJ 2007 The physiology of glucagon-like peptide 1. Physiological Reviews 87 1409–1439. (doi:10.1152/physrev.00034.2006)
24. Huml M, Kobr J, Siala K, Varvarôvská J, Pomahacôvá R, Karlıḱová M & Syḱora J 2011 Gut peptide hormones and pediatric type 1 diabetes mellitus. Physiological Research 60 647–658.
25. Irwin N, Frizelle P, Montgomery IA, Moffett RC, O’Harte FP & Flatt PR 2012 Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK- 8 in mouse models of obesity/diabetes. Diabetologia 55 2747–2758. (doi:10.1007/s00125-012-2654-6)
26. Kappe C, Zhang Q, Nystrӧm T & Sjohölm A 2014 Effects of high-fat diet and the anti-diabetic drug metformin on circulating GLP-1 and the relative number of intestinal L-cells. Diabetology & Metabolic Syndrome 6 70. (doi:10.1186/1758-5996-6-70)
27. Kelly C, McClenaghan NH & Flatt PR 2011 Role ofisletstructure and cellular interactions in the control of insulin secretion. Islets 3 41–47. (doi:10.4161/isl.3.2.14805)
28. Kempaiah P & Kisiel W 2008 Human tissue factor pathway inhibitor-2 induces caspase-mediated apoptosis in a human fibrosarcoma cell line. Apoptosis 13 702–715. (doi:10.1007/s10495-008-0207-8)
29. Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M & Eizirik DL 2004 Free fatty acids and cytokines induce pancreatic b-cell apoptosis by different mechanisms: role of nuclear factor-kB and endoplasmic reticulum stress. Endocrinology 145 5087–5096. (doi:10.1210/en.2004-0478)
30. Kielgast U, Holst JJ & Madsbad S 2011 Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual b-cell function. Diabetes 60 1599–1607. (doi:10.2337/db10- 1790)
31. Kolb H 1987 Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes/Metabolism Reviews 3 751–778. (doi:10.1002/dmr.5610030308)
32. Kolb-Bachofen V, Epstein S, Kiesel U & Kolb H 1988 Low-dose streptozocininduced diabetes in mice. Electron microscopy reveals single-cell insulitis before diabetes onset. Diabetes 37 21–27. (doi:10.2337/diab. 37.1.21)
33. Lakey JR, Suarez-Pinzon WL, Strynadka K, Korbutt GS, Rajotte RV, Mabley JG, Szabó C & Rabinovitch A 2001 Peroxynitrite is a mediator of cytokine-induced destruction of human pancreatic islet β cells. Laboratory Investigation 81 1683–1692. (doi:10.1038/labinvest. 3780381)
34. Larsen L, Tonnesen M, Ronn SG, Størling J, Jørgensen S, Mascagni P, Dinarello CA, Billestrup N & Mandrup-Poulsen T 2007 Inhibition of histone deacetylases prevents cytokine-induced toxicity in b cells. Diabetologia 50 779–789. (doi:10.1007/s00125-006-0562-3)
35. Lechleitner M, Koch T, Herold M, Dzien A & Hoppichler F 2000 Tumour necrosis factor-a plasma level in patients withtype 1 diabetes mellitusand its association with glycaemic control and cardiovascular risk factors. Journal of Internal Medicine 248 67–76. (doi:10.1046/j.1365- 2796.2000.00705.x)
36. Lees Murdock DJ, Barnett YA & Barnett CR 2004 DNA damage and cytotoxicity in pancreatic b-cells expressing human CYP2E1. Biochemical Pharmacology 68 523–530. (doi:10.1016/j.bcp.2004.04.008)
37. Lenzen S 2008 The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51 216–226. (doi:10.1007/s00125-007-0886-7)
38. Li Z, Karlsson FA & Sandler S 2000 Islet loss and a cell expansion in type 1 diabetes induced by multiple low-dose streptozotocin administration in mice. Journal of Endocrinology 165 93–99. (doi:10.1677/joe.0. 1650093)
39. Lortz S, Tiedge M, Nachtwey T, Karlsen AE, Nerup J & Lenzen S 2000 Protection of insulin-producing RINm5F cells against cytokinemediated toxicity through overexpression of antioxidant enzymes. Diabetes 49 1123–1130. (doi:10.2337/diabetes.49.7.1123)
40. Lukić ML, Stosić-Grujicić S & Shahin A 1998 Effector mechanisms in low-dose streptozotocin-induced diabetes. Developmental Immunology 6 119–128. (doi:10.1155/1998/92198)
41. Mechlovich D, Amit T, Mandel SA, Bar-Am O, Bloch K, Vardi P & Youdim MB 2010 The novel multifunctional, iron-chelating drugs M30 and HLA20 protect pancreatic β-cell lines from oxidative stress damage. Journal of Pharmacology and Experimental Therapeutics 333 874–882. (doi:10.1124/ jpet.109.164269)
42. Meerza D, Naseem I & Ahmed J 2012 Effect of 1, 25(OH)2 Vitamin D3 on glucose homeostasis and DNA damage in type 2 diabetic mice. Journal of Diabetes and its Complications 26 363–368. (doi:10.1016/j. jdiacomp.2012.05.013)
43. Meier JJ, Ueberberg S, Korbas S & Schneider S 2011 Diminished glucagons suppression after b-cell reduction is due to impaired a-cell function rather than an expansion of a-cell mass. American Journal of Physiology. Endocrinology and Metabolism 300 E717–E723. (doi:10.1152/ajpendo. 00315.2010)
44. Moore F, Naamane N, Colli ML, Bouckenooghe T, Ortis F, Gurzov EN, Igoillo-Esteve M, Mathieu C, Bontempi G, Thykjaer T et al. 2011 STAT1 is a master regulator of pancreatic β-cell apoptosis and islet inflammation. Journal of Biological Chemistry 286 929–941. (doi:10.1074/jbc. M110.162131)
45. Moore F, Santin I, Nogueira TC, Gurzov EN, Marchetti P & Eizirik DL 2012 The transcription factor C/EBP d has anti-apoptotic and anti-inflammatory roles in pancreatic β cells. PLoS ONE 7 e31062. (doi:10.1371/ journal.pone.0031062)